Celularity (CELU) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.25, -6.02% vs the prior close of $1.33.
- Volume 63.44K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CELU slides 6.0% to $1.25. Closed at $1.25, -6.02% vs the prior close of $1.33. Day range $1.22–$1.33, opened at $1.33.
CELU daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CELU slides 6.0% to $1.25
- Closed at $1.25, -6.02% vs the prior close of $1.33. Day range $1.22–$1.33, opened at $1.33.
- Volume was 63.44K shares, 0.0x its 50-day average of 4.97M — lighter than usual.
- Price is -1.5% vs its 50-day average ($1.27) and +13.5% vs its 200-day average ($1.10).
- 52-week range $0.56–$2.55; today's close sits at 35% of that range, 51.0% below the 52-week high.
Oct 15, 2026 — CELU rises 1.5% to $1.33
- Closed at $1.33, +1.53% vs the prior close of $1.31. Day range $1.27–$1.35, opened at $1.28.
- Volume was 30.60K shares, 0.0x its 50-day average of 4.97M — lighter than usual.
- Price is +5.8% vs its 50-day average ($1.26) and +20.9% vs its 200-day average ($1.10).
- 52-week range $0.56–$2.55; today's close sits at 39% of that range, 47.8% below the 52-week high.
Oct 14, 2026 — CELU slides 7.7% to $1.31, 3 down days in a row
- Closed at $1.31, -7.75% vs the prior close of $1.42. Day range $1.28–$1.41, opened at $1.39.
- Volume was 80.00K shares, 0.0x its 50-day average of 4.97M — lighter than usual.
- Price is +5.2% vs its 50-day average ($1.25) and +19.1% vs its 200-day average ($1.10).
- 52-week range $0.56–$2.55; today's close sits at 38% of that range, 48.6% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — CELU slides 3.4% to $1.42
- Closed at $1.42, -3.40% vs the prior close of $1.47. Day range $1.40–$1.55, opened at $1.45.
- Volume was 50.30K shares, 0.0x its 50-day average of 4.97M — lighter than usual.
- Price is +15.1% vs its 50-day average ($1.23) and +29.1% vs its 200-day average ($1.10).
- 52-week range $0.56–$2.55; today's close sits at 43% of that range, 44.3% below the 52-week high.
Oct 12, 2026 — CELU slides 5.8% to $1.47
- Closed at $1.47, -5.77% vs the prior close of $1.56. Day range $1.46–$1.57, opened at $1.56.
- Volume was 43.60K shares, 0.0x its 50-day average of 4.97M — lighter than usual.
- Price is +20.7% vs its 50-day average ($1.22) and +33.7% vs its 200-day average ($1.10).
- 52-week range $0.56–$2.55; today's close sits at 46% of that range, 42.4% below the 52-week high.
Oct 9, 2026 — CELU jumps 6.8% to $1.56
- Closed at $1.56, +6.85% vs the prior close of $1.46. Day range $1.45–$1.57, opened at $1.46.
- Volume was 53.20K shares, 0.0x its 50-day average of 4.97M — lighter than usual.
- Price is +29.8% vs its 50-day average ($1.20) and +42.0% vs its 200-day average ($1.10).
- 52-week range $0.56–$2.55; today's close sits at 50% of that range, 38.8% below the 52-week high.
Oct 8, 2026 — CELU dips 0.7% to $1.46, 3 down days in a row
- Closed at $1.46, -0.68% vs the prior close of $1.47. Day range $1.43–$1.50, opened at $1.46.
- Volume was 103.70K shares, 0.0x its 50-day average of 4.97M — lighter than usual.
- Price is +23.3% vs its 50-day average ($1.18) and +33.0% vs its 200-day average ($1.10).
- 52-week range $0.56–$2.55; today's close sits at 45% of that range, 42.7% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — CELU slides 7.0% to $1.47
- Closed at $1.47, -6.96% vs the prior close of $1.58. Day range $1.47–$1.57, opened at $1.53.
- Volume was 68.90K shares, 0.0x its 50-day average of 4.97M — lighter than usual.
- Price is +25.8% vs its 50-day average ($1.17) and +34.0% vs its 200-day average ($1.10).
- 52-week range $0.56–$2.55; today's close sits at 46% of that range, 42.4% below the 52-week high.
Oct 6, 2026 — CELU slides 7.6% to $1.58
- Closed at $1.58, -7.60% vs the prior close of $1.71. Day range $1.54–$1.77, opened at $1.70.
- Volume was 260.90K shares, 0.1x its 50-day average of 4.96M — lighter than usual.
- Price is +36.9% vs its 50-day average ($1.15) and +44.1% vs its 200-day average ($1.10).
- 52-week range $0.56–$2.55; today's close sits at 51% of that range, 38.0% below the 52-week high.
Oct 5, 2026 — CELU jumps 6.9% to $1.71, 3 up days in a row
- Closed at $1.71, +6.88% vs the prior close of $1.60. Day range $1.57–$1.80, opened at $1.60.
- Volume was 282.00K shares, 0.1x its 50-day average of 4.96M — lighter than usual.
- Price is +50.3% vs its 50-day average ($1.14) and +56.2% vs its 200-day average ($1.09).
- 52-week range $0.56–$2.55; today's close sits at 58% of that range, 32.9% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — CELU jumps 15.9% to $1.60
- Closed at $1.60, +15.94% vs the prior close of $1.38. Day range $1.36–$1.63, opened at $1.37.
- Volume was 220.50K shares, 0.0x its 50-day average of 4.96M — lighter than usual.
- Price is +43.1% vs its 50-day average ($1.12) and +46.4% vs its 200-day average ($1.09).
- 52-week range $0.56–$2.55; today's close sits at 52% of that range, 37.3% below the 52-week high.
CELU latest news & SEC filings
Every SEC filing by or about CELU in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 29, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Mar 31, 2026:
- Revenue: $3.85M (prior year $11.43M) (-66.3% vs Mar 31, 2025)
- Net income: $874.00K (prior year -$19.75M) (swung to profit vs Mar 31, 2025)
- Diluted EPS: $0.02 (prior year -$0.84) (swung to profit vs Mar 31, 2025)
Sep 28, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form NT 10-Q — Notice of late quarterly report
Notice of late quarterly report
Aug 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jul 22, 2026 · Form 25-NSE — Notice that a security is being removed from exchange listing
Notice that a security is being removed from exchange listing
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jun 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jun 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade CELU
- Last results release: May 9, 2025 (8-K Item 2.02). Previous ones: Nov 7, 2024, Oct 25, 2024, May 21, 2024. Based on that rhythm, the next report is likely around Aug 8, 2025 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.43% (largest 15.9%). That is a volatile stock.
- Liquidity: about 133.24K shares (≈$166.55K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.25 vs a range of $0.56–$2.55 (35% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 29, 2026; 10-Q Sep 29, 2026; 8-K Sep 28, 2026.
- Share count: 32.45M shares outstanding (Sep 24, 2026), +21.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CELU market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.33 | 1.33 | 1.22 | 1.25 | 63.44K |
| Oct 15, 2026 | 1.28 | 1.35 | 1.27 | 1.33 | 30.60K |
| Oct 14, 2026 | 1.39 | 1.41 | 1.28 | 1.31 | 80.00K |
| Oct 13, 2026 | 1.45 | 1.55 | 1.40 | 1.42 | 50.30K |
| Oct 12, 2026 | 1.56 | 1.57 | 1.46 | 1.47 | 43.60K |
| Oct 9, 2026 | 1.46 | 1.57 | 1.45 | 1.56 | 53.20K |
| Oct 8, 2026 | 1.46 | 1.50 | 1.43 | 1.46 | 103.70K |
| Oct 7, 2026 | 1.53 | 1.57 | 1.47 | 1.47 | 68.90K |
| Oct 6, 2026 | 1.70 | 1.77 | 1.54 | 1.58 | 260.90K |
| Oct 5, 2026 | 1.60 | 1.80 | 1.57 | 1.71 | 282.00K |
| Oct 2, 2026 | 1.37 | 1.63 | 1.36 | 1.60 | 220.50K |
| Oct 1, 2026 | 1.34 | 1.38 | 1.30 | 1.38 | 141.80K |
| Sep 30, 2026 | 1.37 | 1.37 | 1.28 | 1.35 | 54.50K |
| Sep 29, 2026 | 1.38 | 1.40 | 1.33 | 1.37 | 39.50K |
| Sep 28, 2026 | 1.40 | 1.46 | 1.35 | 1.40 | 112.20K |
| Sep 25, 2026 | 1.33 | 1.41 | 1.32 | 1.38 | 164.90K |
| Sep 24, 2026 | 1.17 | 1.35 | 1.17 | 1.32 | 449.40K |
| Sep 23, 2026 | 1.17 | 1.18 | 1.13 | 1.15 | 76.70K |
| Sep 22, 2026 | 1.22 | 1.26 | 1.16 | 1.18 | 154.70K |
| Sep 21, 2026 | 1.27 | 1.33 | 1.24 | 1.24 | 214.00K |
About Celularity
Celularity (CELU) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in FLORHAM PARK, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1752828.
CELU board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Philip Alan Barach | Director | Sep 25, 2026 |
| Peter Diamandis | Director | Jan 15, 2026 |
| Robert J Hariri | Chief Executive Officer | Apr 15, 2026 |
| Vincent Levien | Director | Jan 15, 2026 |
| Geoffrey M.D. Ling | Director | Jan 15, 2026 |
| Diane L. Parks | Director | Jan 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Stephen Brigido | Pres., Functional Regeneration | Apr 15, 2026 |
| John R Haines | Senior Exec Vice President | Apr 15, 2026 |
| Robert J Hariri | Chief Executive Officer | Apr 15, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
CELU financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $26.55M | $-91.72M | -3.59 | $-13.25M |
| Dec 31, 2024 | $54.22M | $-57.89M | -2.64 | $-6.40M |
| Dec 31, 2023 | $22.77M | $-196.29M | -11.02 | $-38.69M |
| Dec 31, 2022 | $17.98M | $14.19M | 0.95 | $-137.88M |
| Dec 31, 2021 | $21.34M | $-100.12M | -1.49 | $-110.10M |
Latest balance sheet: total assets $99.48M, total liabilities $134.74M, cash $368.00K (as of Mar 31, 2026).
CELU earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 9, 2025 | 8-K Item 2.02 (results) | $1.67 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $3.09 |
| Oct 25, 2024 | 8-K Item 2.02 (results) | $1.86 |
| May 21, 2024 | 8-K Item 2.02 (results) | — |
| Jan 9, 2024 | 8-K Item 2.02 (results) | — |
| Nov 10, 2022 | 8-K Item 2.02 (results) | — |
| Aug 10, 2022 | 8-K Item 2.02 (results) | — |
| May 16, 2022 | 8-K Item 2.02 (results) | — |
| Mar 31, 2022 | 8-K Item 2.02 (results) | — |
| Nov 12, 2021 | 8-K Item 2.02 (results) | — |
| Aug 16, 2021 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CELU
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.